Smooth and Unobstructed! Medtronic Sentrant™ Guiding Sheath with Hydrophilic Coating Officially Approved in Mainland China

May 27, 2024 07:30 CST Updated 07:30

Medtronic

Medical Device Manufacturer

In today's rapidly advancing interventional technology, every update and iteration of medical devices aims to provide patients with a better quality of life. Medtronic has always been committed to the continuous innovation and introduction of medical devices. The recent official approval of the Sentrant™ Guiding Sheath (with hydrophilic coating) system in mainland China offers clinical doctors and patients a more efficient and safer treatment option.

Unique Hydrophilic Coating Design

As the cornerstone of vascular interventional surgery, the performance of the introducer sheath directly affects the smoothness and safety of the procedure.

Sentrant™ Introducer Sheath, with its unique hydrophilic coating design, significantly enhances the smoothness of the sheath placement process, effectively reducing the resistance and risk of complications that may be encountered during surgery. This makes interventional procedures more manageable.

Diversified models and specifications

The model specifications of the Sentrant™ Introducer Sheath are designed with consideration for the diversity of clinical surgical needs. The size range includes lengths of 28/64cm and diameters from 12-26F. This system is suitable for various vascular access procedures, providing stronger support for interventional surgeries. Comprehensive compatibility: aortic valve intervention, aortic stents, and other application scenarios. A full range of specifications and different length options ensure that surgeons can flexibly select the most appropriate tool based on specific cases, achieving personalized precision treatment and further expanding the application scenarios for interventional procedures.

Believe that with the approval and market launch of the Sentrant™ introducer sheath, it will bring a more minimally invasive and safer treatment experience to patients with vascular diseases in China, ushering in a new era of "smooth" interventional surgery!

Copyright Statement: This platform aims to help healthcare professionals better understand the latest developments in related disease areas. The information published on this platform does not imply agreement with its descriptions or viewpoints, but is merely intended to provide more information. If there are any copyright issues, we kindly request the rights holders to contact us, and we will address them as soon as possible. This information is solely for healthcare professionals to stay informed, and such information cannot replace professional medical guidance in any way, nor should it be considered as medical advice. If such information is used for purposes other than staying informed, this platform and its authors shall not bear any related responsibilities.Contact email for cooperation:vascular@edoctor.work。